Neil D. Minkoff, MD

Payer considerations regarding unintended pregnancy is discussed by Maria Lopes, MD, MS, and Kevin Stephens Sr., MD, JD.

Shared insight on the differences between ACG and IDSA/SHEA treatment guidelines for patients with clostridium difficile infection.

A panel of experts review treatment goals and assessing response in patients with recurrent clostridium difficile infection.

A broad view on the impact of recurrent clostridium difficile infection on patients and the healthcare system at large.

Integrating behavioral and physical health services within an accountable care organization offers a significant opportunity to address both behavioral health conditions and substance use disorders, as well as to improve outcomes and reduce costs.